Maillard reaction and immunogenicity of protein therapeutics

This publication has 234 references indexed in Scilit:

• Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice
  Pharmaceutical Research, 2011
• Genotoxicity and immunogenicity of DNA-advanced glycation end products formed by methylglyoxal and lysine in presence of Cu2+
  Biochemical and Biophysical Research Communications, 2011
• Advanced glycation endproducts: from precursors to RAGE: round and round we go
  Amino Acids, 2010
• Favored and disfavored pathways of protein crosslinking by glucose: glucose lysine dimer (GLUCOLD) and crossline versus glucosepane
  Amino Acids, 2010
• Clinical significance of the humoral immune response to modified LDL
  Clinical Immunology, 2010
• Preferential recognition of Amadori-rich lysine residues by serum antibodies in diabetes mellitus: Role of protein glycation in the disease process
  Human Immunology, 2009
• Identification of 3-deoxyglucosone dehydrogenase as aldehyde dehydrogenase 1A1 (retinaldehyde dehydrogenase 1)
  Biochimie, 2007
• Acid-Stable Fluorescent Advanced Glycation End Products: Vesperlysines A, B, and C Are Formed as Crosslinked Products in the Maillard Reaction between Lysine or Proteins with Glucose
  Biochemical and Biophysical Research Communications, 1997
• Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes
  Biochemical and Biophysical Research Communications, 1990
• Structure of hemoglobin AIc: Nature of the N-terminal β chain blocking group
  Biochemical and Biophysical Research Communications, 1968